Understanding Illinois' new cannabis, hemp laws and research implications

https://www.linkedin.com/in/agnes-balla-mpp-33025454/" class="text-blue-600 leading-[inherit] cursor-pointer underline" style="cursor: text;">Agnes Balla, Director of Research, Policy Analysis, and Coordination at the University of California Office of the President, and https://www.linkedin.com/in/christina-sansone-3a9477100/" class="text-blue-600 leading-[inherit] cursor-pointer underline" style="cursor: text;">Christina Sansone, Senior Program Manager at https://www.linkedin.com/company/cannabis-research-institute" class="text-blue-600 leading-[inherit] cursor-pointer underline" style="cursor: text;">the Cannabis Research Institute, University of Illinois at Chicago, will discuss recent changes to Illinois cannabis and hemp laws and how those changes will impact research.

Intended audience

• Researchers interested in working with hemp-derived cannabinoids and/or medical cannabis patient data 

• Graduate students, postdocs, and trainees in relevant fields 

Key takeaways 

• Overview of key hemp and cannabis changes in SB 3222: The presenters will provide a high-level overview of SB 3222, Illinois’s updated cannabis and hemp laws, including what’s changed and why it matters for patients, businesses, communities, and researchers.

• What this means for research: Attendees will gain a practical understanding of how these changes may affect research, including work involving hemp-derived cannabinoids and medical cannabis data.

• Register here